Prediction of cochlear implant performance by genetic mutation: The spiral ganglion hypothesis

Hearing Research

Volumn 292, Issue 1-2, 2012, Pages 51-58

  Eppsteiner, Robert W ^a   Shearer, A Eliot ^a,b   Hildebrand, Michael S ^a   DeLuca, Adam P ^c,d   Ji, Haihong ^a   Dunn, Camille C ^a   Black Ziegelbein, Elizabeth A ^d   Casavant, Thomas L ^c,d   Braun, Terry A ^c,d   Scheetz, Todd E ^a,c,d   Scherer, Steven E ^e   Hansen, Marlan R ^a   Gantz, Bruce J ^a   Smith, Richard J H ^a,b,d  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c IA United States   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; AUDIOMETRY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COCHLEA PROSTHESIS; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; HEARING LOSS; HUMAN; INNER EAR; LIPOXYGENASE HOMOLOGY DOMAIN CONTAINING 1 GENE; MALE; MITOCHONDRIAL GENE; MUTATOR GENE; PREDICTION; PRIORITY JOURNAL; SPIRAL GANGLION; TRANSMEMBRANE PROTEASE SERINE 3 GENE; VESTIBULOCOCHLEAR NERVE DISEASE;

ACOUSTIC STIMULATION; ADULT; AGED; ANALYSIS OF VARIANCE; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; CORRECTION OF HEARING IMPAIRMENT; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEARING IMPAIRED PERSONS; HEARING LOSS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PATIENT SELECTION; PHENOTYPE; SERINE ENDOPEPTIDASES; SEVERITY OF ILLNESS INDEX; SPIRAL GANGLION;

EID: 84866609335     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2012.08.007     Document Type: Article

References (81)

1. Angeli S.I., Suarez H., Lopez A., Balkany T.J., Liu X.Z. Influence of DFNB1 status on expressive language in deaf children with cochlear implants. Otol. Neurotol. 2011, 32(9):1437-1443.
2. Archbold S.M., Nikolopoulos T.P., Lloyd-Richmond H. Long-term use of cochlear implant systems in paediatric recipients and factors contributing to non-use. Cochlear Implant. Int. 2009, 10(1):25-40.
3. Arndt S., Aschendorff A., Schild C., Beck R., Maier W., Laszig R., Birkenhager R. A novel dominant and a de novo mutation in the GJB2 gene (connexin-26) cause keratitis-ichthyosis-deafness syndrome: implication for cochlear implantation. Otol. Neurotol. 2010, 31(2):210-215.
4. Bauer P.W., Geers A.E., Brenner C., Moog J.S., Smith R.J. The effect of GJB2 allele variants on performance after cochlear implantation. Laryngoscope 2003, 113(12):2135-2140.
5. Brookes J.T., Kanis A.B., Tan L.Y., Tranebjaerg L., Vore A., Smith R.J. Cochlear implantation in deafness-dystonia-optic neuronopathy (DDON) syndrome. Int. J. Pediatr. Otorhinolaryngol. 2008, 72(1):121-126.
6. Brownstein Z., Friedman L.M., Shahin H., Oron-Karni V., Kol N., Rayyan A.A., Parzefall T., Lev D., Shalev S., Frydman M., Davidov B., Shohat M., Rahile M., Lieberman S., Levy-Lahad E., Lee M.K., Shomron N., King M.C., Walsh T., Kanaan M., Avraham K.B. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families. Genome Biol. 2011, 12(9):R89.
7. Cheng A.K., Rubin H.R., Powe N.R., Mellon N.K., Francis H.W., Niparko J.K. Cost-utility analysis of the cochlear implant in children. JAMA 2000, 284(7):850-856.
8. Chora J.R., Matos T.D., Martins J.H., Alves M.C., Andrade S.M., Silva L.F., Ribeiro C.A., Antunes M.C., Fialho M.G., Caria M.H. DFNB1-associated deafness in Portuguese cochlear implant users: prevalence and impact on oral outcome. Int. J. Pediatr. Otorhinolaryngol. 2010, 74(10):1135-1139.
9. Chorbachi R., Graham J.M., Ford J., Raine C.H. Cochlear implantation in Jervell and Lange-Nielsen syndrome. Int. J. Pediatr. Otorhinolaryngol. 2002, 66(3):213-221.
10. Choung Y.H., Shin Y.R., Kim H.J., Kim Y.C., Ahn J.H., Choi S.J., Jeong S.Y., Park K. Cochlear implantation and connexin expression in the child with keratitis-ichthyosis-deafness syndrome. Int. J. Pediatr. Otorhinolaryngol. 2008, 72(6):911-915.
11. Clopton B.M., Spelman F.A., Miller J.M. Estimates of essential neural elements for stimulation through a cochlear prosthesis. Ann. Otol. Rhinol. Laryngol. Suppl. 1980, 89(2 Pt 2):5-7.
12. Colletti L., Mandala M., Shannon R.V., Colletti V. Estimated net saving to society from cochlear implantation in infants: a preliminary analysis. Laryngoscope 2011, 121(11):2455-2460.
13. Connell S.S., Angeli S.I., Suarez H., Hodges A.V., Balkany T.J., Liu X.Z. Performance after cochlear implantation in DFNB1 patients. Otolaryngol. Head. Neck. Surg. 2007, 137(4):596-602.
14. Counter P.R., Hilton M.P., Webster D., Wardell T., Taylor R.W., Besley G., Turnbull D.M., Robinson P.J. Cochlear implantation of a patient with a previously undescribed mitochondrial DNA defect. J. Laryngol. Otol. 2001, 115(9):730-732.
15. Cullen R.D., Buchman C.A., Brown C.J., Copeland B.J., Zdanski C., Pillsbury H.C., Shores C.G. Cochlear implantation for children with GJB2-related deafness. Laryngoscope 2004, 114(8):1415-1419.
16. Dahl H.H., Wake M., Sarant J., Poulakis Z., Siemering K., Blamey P. Language and speech perception outcomes in hearing-impaired children with and without connexin 26 mutations. Audiol. Neurootol. 2003, 8(5):263-268.
17. Dalamon V., Lotersztein V., Lipovsek M., Beheran A., Mondino M.E., Diamante F., Pallares N., Diamante V., Elgoyhen A.B. Performance of speech perception after cochlear implantation in DFNB1 patients. Acta Otolaryngol. 2009, 129(4):395-398.
18. Daneshi A., Hassanzadeh S., Emamdjomeh H., Mohammadi S.H., Arzhangi S., Farhadi M., Najmabadi H. Prevalence of GJB2-associated deafness and outcomes of cochlear implantation in Iran. J. Laryngol. Otol. 2011, 125(5):455-459.
19. de Wolf M.J., Honings J., Joosten F.B., Hoefsloot L., Mylanus E.A., Cremers C.W. Two siblings with progressive, fluctuating hearing loss after head trauma, treated with cochlear implantation. J. Laryngol. Otol. 2010, 124(1):86-89.
20. Edvardson S., Jalas C., Shaag A., Zenvirt S., Landau C., Lerer I., Elpeleg O. A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews. Am. J. Med. Genet. A 2011, 155A(5):1170-1172.
21. Elbracht M., Senderek J., Eggermann T., Thurmer C., Park J., Westhofen M., Zerres K. Autosomal recessive postlingual hearing loss (DFNB8): compound heterozygosity for two novel TMPRSS3 mutations in German siblings. J. Med. Genet. 2007, 44(6):e81.
22. Fasquelle L., Scott H.S., Lenoir M., Wang J., Rebillard G., Gaboyard S., Venteo S., Francois F., Mausset-Bonnefont A.L., Antonarakis S.E., Neidhart E., Chabbert C., Puel J.L., Guipponi M., Delprat B. Tmprss3, a transmembrane serine protease deficient in human DFNB8/10 deafness, is critical for cochlear hair cell survival at the onset of hearing. J. Biol. Chem. 2011, 286(19):17383-17397.
23. Fukushima K., Sugata K., Kasai N., Fukuda S., Nagayasu R., Toida N., Kimura N., Takishita T., Gunduz M., Nishizaki K. Better speech performance in cochlear implant patients with GJB2-related deafness. Int. J. Pediatr. Otorhinolaryngol. 2002, 62(2):151-157.
24. Gerard J.M., Deggouj N., Hupin C., Buisson A.L., Monteyne V., Lavis C., Dahan K., Gersdorff M. Evolution of communication abilities after cochlear implantation in prelingually deaf children. Int. J. Pediatr. Otorhinolaryngol. 2010, 74(6):642-648.
25. Green G.E., Scott D.A., McDonald J.M., Teagle H.F., Tomblin B.J., Spencer L.J., Woodworth G.G., Knutson J.F., Gantz B.J., Sheffield V.C., Smith R.J. Performance of cochlear implant recipients with GJB2-related deafness. Am. J. Med. Genet. 2002, 109(3):167-170.
26. Grillet N., Schwander M., Hildebrand M.S., Sczaniecka A., Kolatkar A., Velasco J., Webster J.A., Kahrizi K., Najmabadi H., Kimberling W.J., Stephan D., Bahlo M., Wiltshire T., Tarantino L.M., Kuhn P., Smith R.J., Muller U. Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. Am. J. Hum. Genet. 2009, 85(3):328-337.
27. Grimberg J., Nawoschik S., Belluscio L., McKee R., Turck A., Eisenberg A. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res. 1989, 17(20):8390.
28. Guipponi M., Vuagniaux G., Wattenhofer M., Shibuya K., Vazquez M., Dougherty L., Scamuffa N., Guida E., Okui M., Rossier C., Hancock M., Buchet K., Reymond A., Hummler E., Marzella P.L., Kudoh J., Shimizu N., Scott H.S., Antonarakis S.E., Rossier B.C. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. Hum. Mol. Genet. 2002, 11(23):2829-2836.
29. Hildebrand M.S., de Silva M.G., Gardner R.J., Rose E., de Graaf C.A., Bahlo M., Dahl H.H. Cochlear implants for DFNA17 deafness. Laryngoscope 2006, 116(12):2211-2215.
30. Hutchin T., Coy N.N., Conlon H., Telford E., Bromelow K., Blaydon D., Taylor G., Coghill E., Brown S., Trembath R., Liu X.Z., Bitner-Glindzicz M., Mueller R. Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK - Implications for genetic testing. Clin. Genet. 2005, 68(6):506-512.
31. Karamert R., Bayazit Y.A., Altinyay S., Yilmaz A., Menevse A., Gokdogan O., Gokdogan C., Ant A. Association of GJB2 gene mutation with cochlear implant performance in genetic non-syndromic hearing loss. Int. J. Pediatr. Otorhinolaryngol. 2011, 75(12):1572-1575.
32. Lai R., Hu P., Zhu F., Zhu G., Vivero R., Peng A., Wu W., Xiao Z., Liu X., Xie D. Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. J. Laryngol. Otol. 2012, 126(4):349-355.
33. Lalwani A.K., Linthicum F.H., Wilcox E.R., Moore J.K., Walters F.C., San Agustin T.B., Mislinski J., Miller M.R., Sinninger Y., Attaie A., Luxford W.M. A five-generation family with late-onset progressive hereditary hearing impairment due to cochleosaccular degeneration. Audiol. Neurootol. 1997, 2(3):139-154.
34. Lanson B.G., Green J.E., Roland J.T., Lalwani A.K., Waltzman S.B. Cochlear implantation in Children with CHARGE syndrome: therapeutic decisions and outcomes. Laryngoscope 2007, 117(7):1260-1266.
35. Lee H.K., Lee S.H., Lee K.Y., Lim E.J., Choi S.Y., Park R.K., Kim U.K. Novel POU3F4 mutations and clinical features of DFN3 patients with cochlear implants. Clin. Genet. 2009, 75(6):572-575.
36. Li H., Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010, 26(5):589-595.
37. Liu X.Z., Angeli S.I., Rajput K., Yan D., Hodges A.V., Eshraghi A., Telischi F.F., Balkany T.J. Cochlear implantation in individuals with Usher type 1 syndrome. Int. J. Pediatr. Otorhinolaryngol. 2008, 72(6):841-847.
38. Loundon N., Marcolla A., Roux I., Rouillon I., Denoyelle F., Feldmann D., Marlin S., Garabedian E.N. Auditory neuropathy or endocochlear hearing loss?. Otol. Neurotol. 2005, 26(4):748-754.
39. Lustig L.R., Lin D., Venick H., Larky J., Yeagle J., Chinnici J., Polite C., Mhatre A.N., Niparko J.K., Lalwani A.K. GJB2 gene mutations in cochlear implant recipients: prevalence and impact on outcome. Arch. Otolaryngol. Head. Neck. Surg. 2004, 130(5):541-546.
40. Luxford W.M., Ad Hoc Subcommittee of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery Minimum speech test battery for postlingually deafened adult cochlear implant patients. Otolaryngol. Head. Neck. Surg. 2001, 124(2):125-126.
41. Makishima T., Kurima K., Brewer C.C., Griffith A.J. Early onset and rapid progression of dominant nonsyndromic DFNA36 hearing loss. Otol. Neurotol. 2004, 25(5):714-719.
42. Mason J.C., De Michele A., Stevens C., Ruth R.A., Hashisaki G.T. Cochlear implantation in patients with auditory neuropathy of varied etiologies. Laryngoscope 2003, 113(1):45-49.
43. Matsushiro N., Doi K., Fuse Y., Nagai K., Yamamoto K., Iwaki T., Kawashima T., Sawada A., Hibino H., Kubo T. Successful cochlear implantation in prelingual profound deafness resulting from the common 233delC mutation of the GJB2 gene in the Japanese. Laryngoscope 2002, 112(2):255-261.
44. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20(9):1297-1303.
45. Mhatre A.N., Li Y., Atkin G., Maghnouj A., Lalwani A.K. Expression of Myh9 in the mammalian cochlea: localization within the stereocilia. J. Neurosci. Res. 2006, 84(4):809-818.
46. Mohr P.E., Feldman J.J., Dunbar J.L., McConkey-Robbins A., Niparko J.K., Rittenhouse R.K., Skinner M.W. The societal costs of severe to profound hearing loss in the United States. Int. J. Technol. Assess. Health Care 2000, 16(4):1120-1135.
47. Nadol J.B., Merchant S.N. Histopathology and molecular genetics of hearing loss in the human. Int. J. Pediatr. Otorhinolaryngol. 2001, 61(1):1-15.
48. Nadol J.B., Young Y.S., Glynn R.J. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann. Otol. Rhinol. Laryngol. 1989, 98(6):411-416.
49. Nilsson M., Soli S.D., Sullivan J.A. Development of the Hearing in Noise Test for the measurement of speech reception thresholds in quiet and in noise. J. Acoust. Soc. Am. 1994, 95(2):1085-1099.
50. Pennings R.J., Damen G.W., Snik A.F., Hoefsloot L., Cremers C.W., Mylanus E.A. Audiologic performance and benefit of cochlear implantation in Usher syndrome type I. Laryngoscope 2006, 116(5):717-722.
51. Peterson G.E., Lehiste I. Revised CNC lists for auditory tests. J. Speech Hear. Disord. 1962, 27:62-70.
52. Raine C.H., Summerfield Q., Strachan D.R., Martin J.M., Totten C. The cost and analysis of nonuse of cochlear implants. Otol. Neurotol. 2008, 29(2):221-224.
53. Reinert J., Honegger F., Gurtler N. High homogeneity in auditory outcome of pediatric CI-patients with mutations in Gap-Junction-Protein Beta2. Int. J. Pediatr. Otorhinolaryngol. 2010, 74(7):791-795.
54. Rodriguez-Ballesteros M., del Castillo F.J., Martin Y., Moreno-Pelayo M.A., Morera C., Prieto F., Marco J., Morant A., Gallo-Teran J., Morales-Angulo C., Navas C., Trinidad G., Tapia M.C., Moreno F., del Castillo I. Auditory neuropathy in patients carrying mutations in the otoferlin gene (OTOF). Hum. Mutat. 2003, 22(6):451-456.
55. Rodriguez-Ballesteros M., Reynoso R., Olarte M., Villamar M., Morera C., Santarelli R., Arslan E., Meda C., Curet C., Volter C., Sainz-Quevedo M., Castorina P., Ambrosetti U., Berrettini S., Frei K., Tedin S., Smith J., Cruz Tapia M., Cavalle L., Gelvez N., Primignani P., Gomez-Rosas E., Martin M., Moreno-Pelayo M.A., Tamayo M., Moreno-Barral J., Moreno F., del Castillo I. A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy. Hum. Mutat. 2008, 29(6):823-831.
56. Rouillon I., Marcolla A., Roux I., Marlin S., Feldmann D., Couderc R., Jonard L., Petit C., Denoyelle F., Garabedian E.N., Loundon N. Results of cochlear implantation in two children with mutations in the OTOF gene. Int. J. Pediatr. Otorhinolaryngol. 2006, 70(4):689-696.
57. Roush P., Frymark T., Venediktov R., Wang B. Audiologic management of auditory neuropathy spectrum disorder in children: a systematic review of the literature. Am. J. Audiol. 2011, 20(2):159-170.
58. Rubinstein J.T., Parkinson W.S., Tyler R.S., Gantz B.J. Residual speech recognition and cochlear implant performance: effects of implantation criteria. Am. J. Otol. 1999, 20(4):445-452.
59. Santarelli R. Information from cochlear potentials and genetic mutations helps localize the lesion site in auditory neuropathy. Genome Med. 2010, 2(12):91.
60. Shearer A.E., DeLuca A.P., Hildebrand M.S., Taylor K.R., Gurrola J., Scherer S., Scheetz T.E., Smith R.J. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc. Natl. Acad. Sci. USA 2010, 107(49):21104-21109.
61. Siem G., Fruh A., Leren T.P., Heimdal K., Teig E., Harris S. Jervell and Lange-Nielsen syndrome in Norwegian children: aspects around cochlear implantation, hearing, and balance. Ear Hear. 2008, 29(2):261-269.
62. Sinnathuray A.R., Toner J.G., Clarke-Lyttle J., Geddis A., Patterson C.C., Hughes A.E. Connexin 26 (GJB2) gene-related deafness and speech intelligibility after cochlear implantation. Otol. Neurotol. 2004, 25(6):935-942.
63. Sinnathuray A.R., Toner J.G., Geddis A., Clarke-Lyttle J., Patterson C.C., Hughes A.E. Auditory perception and speech discrimination after cochlear implantation in patients with connexin 26 (GJB2) gene-related deafness. Otol. Neurotol. 2004, 25(6):930-934.
64. Song M.H., Cho H.J., Lee H.K., Kwon T.J., Lee W.S., Oh S., Bok J., Choi J.Y., Kim U.K. CHD7 mutational analysis and clinical considerations for auditory rehabilitation in deaf patients with CHARGE syndrome. PLoS One 2011, 6(9):e24511.
65. Stankovic K.M., Hennessey A.M., Herrmann B., Mankarious L.A. Cochlear implantation in children with congenital X-linked deafness due to novel mutations in POU3F4 gene. Ann. Otol. Rhinol. Laryngol. 2010, 119(12):815-822.
66. Taitelbaum-Swead R., Brownstein Z., Muchnik C., Kishon-Rabin L., Kronenberg J., Megirov L., Frydman M., Hildesheimer M., Avraham K.B. Connexin-associated deafness and speech perception outcome of cochlear implantation. Arch. Otolaryngol. Head. Neck. Surg. 2006, 132(5):495-500.
67. Tang W., Qian D., Ahmad S., Mattox D., Todd N.W., Han H., Huang S., Li Y., Wang Y., Li H., Lin X. A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet. Test. Mol. Biomarkers 2012.
68. Teagle H.F., Roush P.A., Woodard J.S., Hatch D.R., Zdanski C.J., Buss E., Buchman C.A. Cochlear implantation in children with auditory neuropathy spectrum disorder. Ear Hear. 2010, 31(3):325-335.
69. Tomblin J.B., Spencer L., Flock S., Tyler R., Gantz B. A comparison of language achievement in children with cochlear implants and children using hearing aids. J. Speech Lang. Hear. Res. 1999, 42(2):497-509.
70. Tono T., Kiyomizu K., Matsuda K., Komune S., Usami S., Abe S., Shinkawa H. Different clinical characteristics of aminoglycoside-induced profound deafness with and without the 1555 A-->G mitochondrial mutation. ORL J. Otorhinolaryngol. Relat. Spec. 2001, 63(1):25-30.
71. Turchetti G., Bellelli S., Palla I., Berrettini S. Systematic review of the scientific literature on the economic evaluation of cochlear implants in adult patients. Acta Otorhinolaryngol. Ital. 2011, 31(5):319-327.
72. Ulubil S.A., Furze A.D., Angeli S.I. Cochlear implantation in a patient with profound hearing loss with the A1555G mitochondrial DNA mutation and no history of aminoglycoside exposure. J. Laryngol. Otol. 2006, 120(3):230-232.
73. Vermeire K., Brokx J.P., Wuyts F.L., Cochet E., Hofkens A., De Bodt M., Van de Heyning P.H. Good speech recognition and quality-of-life scores after cochlear implantation in patients with DFNA9. Otol. Neurotol. 2006, 27(1):44-49.
74. Vescan A., Parnes L.S., Cucci R.A., Smith R.J., MacNeill C. Cochlear implantation and Pendred's syndrome mutation in monozygotic twins with large vestibular aqueduct syndrome. J. Otolaryngol. 2002, 31(1):54-57.
75. Weegerink N.J., Pennings R.J., Huygen P.L., Hoefsloot L.H., Cremers C.W., Kunst H.P. Phenotypes of two Dutch DFNA3 families with mutations in GJB2. Ann. Otol. Rhinol. Laryngol. 2011, 120(3):191-197.
76. Weegerink N.J., Schraders M., Oostrik J., Huygen P.L., Strom T.M., Granneman S., Pennings R.J., Venselaar H., Hoefsloot L.H., Elting M., Cremers C.W., Admiraal R.J., Kremer H., Kunst H.P. Genotype-phenotype correlation in DFNB8/10 families with TMPRSS3 mutations. J. Assoc. Res. Otolaryngol. 2011, 12(6):753-766.
77. Wrobel M., Magierska-Krzyszton M., Szyfter K., Mietkiewska D., Szyfter W., Rydzanicz M., Szyfter K., Karlik M. Comparison of rehabilitation results in deaf patients with and without genetically related hearing loss. Cochlear Implant. Int. 2008, 9(3):132-142.
78. Wu C.C., Lee Y.C., Chen P.J., Hsu C.J. Predominance of genetic diagnosis and imaging results as predictors in determining the speech perception performance outcome after cochlear implantation in children. Arch. Pediatr. Adolesc. Med. 2008, 162(3):269-276.
79. Wu C.C., Liu T.C., Wang S.H., Hsu C.J., Wu C.M. Genetic characteristics in children with cochlear implants and the corresponding auditory performance. Laryngoscope 2011, 121(6):1287-1293.
80. Yasunaga S., Grati M., Cohen-Salmon M., El-Amraoui A., Mustapha M., Salem N., El-Zir E., Loiselet J., Petit C. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet. 1999, 21(4):363-369.
81. Yoshikawa S., Kawano A., Hayashi C., Nishiyama N., Kawaguchi S., Furuse H., Ikeda K., Suzuki M., Nakagawa M. The clinical features of patients with the homozygous 235delC and the compound-heterozygous Y136X/G45E of the GJB2 mutations (Connexin 26) in cochlear implant recipients. Auris Nasus Larynx 2011, 38(4):444-449.